申请人:NatureWise Biotech & Medicals Corporation
公开号:EP2783684A1
公开(公告)日:2014-10-01
The present invention is directed to a novel use of prenylflavanone compounds for control of blood glucose and treatment or prevention of diabetes.
本发明涉及一种控制血糖和治疗或预防糖尿病的前黄烷酮化合物的新用途。